Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy.

Sarcoma · 2018 · PMC5901828 · PMID 29808081

Europe PMC DOI

hedged sentence

0.2100

closest p · 4.2× alpha

0.2100

boldest claim

The sentences

did not reach statistical significancep value = 0.21not close (p > 0.1)

While a history of prior metastasectomy did show a trend towards longer survival, this did not reach statistical significance (median survival 96.8 months with prior metastasectomy versus 46.3 months without metastasectomy, p value = 0.21) ( Figure 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.